These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 22440874
21. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus J. Strahlenther Onkol; 2005 Jun; 181(6):372-7. PubMed ID: 15925979 [Abstract] [Full Text] [Related]
22. Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology? Binello E, Germano IM. J Neurooncol; 2009 Aug; 94(1):145-8. PubMed ID: 19199004 [Abstract] [Full Text] [Related]
24. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A. Anticancer Res; 2003 Apr 01; 23(6D):5159-64. PubMed ID: 14981983 [Abstract] [Full Text] [Related]
26. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma. Hamilton DA. Cancer Treat Rev; 2006 Oct 01; 32(6):483-6. PubMed ID: 16730911 [No Abstract] [Full Text] [Related]
27. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P. J Clin Oncol; 2005 Apr 01; 23(10):2372-7. PubMed ID: 15800329 [Abstract] [Full Text] [Related]
29. Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma. Clark SW, Taylor J, Wang DL, Abramson JS, Batchelor TT. Neurology; 2013 Jul 02; 81(1):93-4. PubMed ID: 23685934 [No Abstract] [Full Text] [Related]
30. Adjuvant temozolomide: how long and how much? Franceschi E, Tosoni A, Brandes AA. Expert Rev Anticancer Ther; 2008 May 02; 8(5):663-5. PubMed ID: 18471038 [No Abstract] [Full Text] [Related]
32. [Temozolomide, an oral chemotherapeutic agent with potential severe toxicity]. Soetekouw PM, Gijtenbeek JM, van der Maazen RW, Kappelle AC, van Herpen CM. Ned Tijdschr Geneeskd; 2007 Jan 27; 151(4):253-7. PubMed ID: 17323884 [Abstract] [Full Text] [Related]